Search for Clinical Trial Results

Sponsored By

Acute Graft Versus Host Disease - 162 Studies Found

Status Study
Completed Study Name: Extracorporeal Photopheresis in Children and Young Adults With Refractory Acute Graft Versus Host Disease
Condition: Graft Versus Host Disease
Date: 2008-12-18
Interventions: Procedure: ECP (performed on Themos UVAR-XTS or external UVA irradiator after cell collection by apheresis)
Terminated Study Name: Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)
Condition: Glucocorticosteroid Refractory Acute GVHD
Date: 2012-12-13
Interventions: Drug: Toclizumab 8 mg/kg IV, once every 1-2 weeks. The maximum dose per infusion should not exceed 800 m
Completed Study Name: GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease
Condition: Graft vs Host Disease
Date: 2005-09-27
Interventions: Drug: Infliximab
Completed Study Name: A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation
Condition:
  • Graft vs Host Disease
  • Peripheral Blood Stem Cell Transplantation
  • Drug: Tacrolimus Tacrolimus as
Completed Study Name: Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD)
Condition: Graft-Versus-Host Disease
Date: 2010-04-16
Interventions: Drug: Panobinostat (LBH589) Phase I Initial Treatment Plan
Completed Study Name: A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH1)
Condition: Graft-versus-host Disease
Date: 2016-11-01
Interventions:
  • Drug: Ruxolitinib Other Names:
Completed Study Name: Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD)
Condition: Blood Stem Cell Transplant Failure
Date: 2012-03-29
Completed Study Name: Topical Vitamin D in Acute Graft Versus Host Disease of the Skin
Condition: Graft Vs Host Disease
Date: 2017-03-23
Interventions: Dietary Supplement: Calcipotriene Topical vitamin D cream will be applied to affected areas of the skin.
Completed Study Name: Decidual Stromal Cells as Treatment for Acute Graft Versus Host Disease, a Phase 1-2 Study
Condition: Graft vs Host Disease
Date: 2014-06-17
Interventions:
  • Biological: Decidual Stromal Cells thawed in plasma
Completed Study Name: Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease
Condition: Graft-Versus-Host Disease
Date: 2005-09-12
Interventions: Drug: Pentostatin Pentostatin is given at a dose of 1.5 mg/m2/day IV x 3 consecutive days. Each IV infus
<<< Previous | Next >>>